* Molecular docking and simulations indicate that these candidates have a strong binding affinity to DPP4, maintaining stable interactions throughout a 200 ns simulation with observed H-bonding.
* The findings suggest that these compounds could act as effective DPP4 inhibitors, potentially leading to new treatments for type 2 diabetes.